Product code NG-MIC-007
Format: Microencapsulated Powder Release: Immediate / non-modified
Single-active microencapsulated powder designed for low-dose uniformity, stability and interaction with oth...
Product code NG-MIC-008
Format: Microencapsulated Powder Release: Immediate / non-modified
Single-active microencapsulated powder designed for dry-powder conversion, potency protection and accurate ...
Product code NG-LIP-001
Format: Single-active dry powder Release: Immediate / non-modified
Liposomal Vitamin K2 MK-7 Powder is a single-active, immediate-release ingredient developed for low-dose un...
Product code NG-LIP-002
Format: Liposomal Powder Release: Immediate / non-modified
Single-active liposomal powder designed for dry-powder presentation, low-dose distribution and dispersion o...
Product code NG-LIP-005
Format: Liposomal Powder Release: Immediate / non-modified
Single-active liposomal powder designed for moisture sensitivity, matrix interaction and formulation disper...
Technical selection guide
This collection brings together vitamin actives across liposomal and microencapsulated platforms. Selection should consider dose uniformity, stability, dispersion, ingredient interactions and evidence for the specific delivery system.
Microgram-level vitamin use can make content uniformity and distribution across a larger powder blend important formulation considerations.
Formulators should evaluate premixing, particle-size compatibility, segregation risk and assay uniformity in the finished product rather than relying on nominal ingredient loading alone.
Compare active form, assay, carrier system, release behaviour, structural or performance evidence and suitability for the intended dosage form.
The technologies have different objectives and evidence requirements. Neither term should be treated as an automatic modified-release or human-bioavailability claim.
Verify the current specification and request any applicable batch CoA, stability and characterisation information, together with ingredient-level regulatory information for the intended use.
The customer must confirm dose, national requirements, label declarations, claims, processing compatibility and finished-product performance.
